PMID | Title | Journal | Publication Year | Author | View in RVdb |
---|---|---|---|---|---|
30563098 | Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy? | Cancers (Basel) | 2018 | Stepanenko AA;Chekhonin VP | View More |
33875611 | Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma. | J Immunother Cancer | 2021 | Beasley GM;Nair SK;Farrow NE;Landa K;Selim MA;Wiggs CA;Jung SH;Bigner DD;True Kelly A;Gromeier M;Salama AK | View More |
34503272 | Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy. | Cancers (Basel) | 2021 | Burnett WJ;Burnett DM;Parkman G;Ramstead A;Contreras N;Gravley W;Holmen SL;Williams MA;VanBrocklin MW | View More |
35674873 | Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice. | Neurotherapeutics | 2022 | Shoaf ML;Desjardins A | View More |
37313455 | Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses. | Mol Ther Oncolytics | 2023 | Webb MJ;Kottke T;Kendall BL;Swanson J;Uzendu C;Tonne J;Thompson J;Metko M;Moore M;Borad M;Roberts L;Diaz RM;Olin M;Borgatti A;Vile R | View More |